Cargando…
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what...
Autores principales: | Griffith, Jessica I., Rathi, Sneha, Zhang, Wenqiu, Zhang, Wenjuan, Drewes, Lester R., Sarkaria, Jann N., Elmquist, William F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763839/ https://www.ncbi.nlm.nih.gov/pubmed/33322488 http://dx.doi.org/10.3390/pharmaceutics12121205 |
Ejemplares similares
-
BBB pathophysiology–independent delivery of siRNA in traumatic brain injury
por: Li, Wen, et al.
Publicado: (2021) -
Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
por: Satapathy, Mantosh Kumar, et al.
Publicado: (2021) -
BBB building
por: Robinson, Richard
Publicado: (2008) -
Stealth and Cationic Nanoliposomes as Drug Delivery Systems to Increase Andrographolide BBB Permeability
por: Piazzini, Vieri, et al.
Publicado: (2018) -
Nanoparticle delivery through the BBB in central nervous system tuberculosis
por: Griego, Anna, et al.
Publicado: (2023)